Rani Therapeutics Holdings annual operating expenses
2020
2021
2022
2023
2024
2025
Rani Therapeutics Holdings Operating Expenses Growth & History (RANI)
Rani Therapeutics Holdings's operating expenses was $39.9M for fiscal 2025.
View full Rani Therapeutics Holdings company overviewRani Therapeutics Holdings annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $39.9M | −$14.4M | −26.50% |
| 2024 | 2024-12-31 | $54.3M | −$11.8M | −17.79% |
| 2023 | 2023-12-31 | $66.1M | $2.6M | +4.17% |
| 2022 | 2022-12-31 | $63.5M | $9.1M | +16.82% |
| 2021 | 2021-12-31 | $54.3M | $37.3M | +219.39% |
| 2020 | 2020-12-31 | $17.0M | — | — |
Rani Therapeutics Holdings quarterly operating expenses
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $10.5M | $31,000 | +0.30% |
| Q1 2026 | 2026-03-31 | $10.0M | −$2.1M | −17.55% |
| Q4 2025 | 2025-12-31 | $10.0M | −$6.0M | −37.47% |
| Q3 2025 | 2025-09-30 | $7.3M | −$4.5M | −38.49% |
| Q2 2025 | 2025-06-30 | $10.5M | −$2.0M | −16.12% |
| Q1 2025 | 2025-03-31 | $12.2M | −$1.8M | −13.18% |
| Q4 2024 | 2024-12-31 | $16.0M | $2.6M | +18.99% |
| Q3 2024 | 2024-09-30 | $11.8M | −$6.1M | −33.92% |
| Q2 2024 | 2024-06-30 | $12.5M | −$5.8M | −31.54% |
| Q1 2024 | 2024-03-31 | $14.0M | −$2.5M | −15.03% |
| Q4 2023 | 2023-12-31 | $13.4M | −$4.0M | −23.16% |
| Q3 2023 | 2023-09-30 | $17.9M | $1.5M | +9.26% |
| Q2 2023 | 2023-06-30 | $18.3M | $2.4M | +15.44% |
| Q1 2023 | 2023-03-31 | $16.5M | $2.7M | +19.85% |
| Q4 2022 | 2022-12-31 | $17.5M | $4.1M | +30.83% |
| Q3 2022 | 2022-09-30 | $16.3M | −$11.4M | −41.18% |
| Q2 2022 | 2022-06-30 | $15.8M | $8.6M | +119.52% |
| Q1 2022 | 2022-03-31 | $13.8M | $7.8M | +131.44% |
| Q4 2021 | 2021-12-31 | $13.4M | — | — |
| Q3 2021 | 2021-09-30 | $27.8M | $24.8M | +846.54% |
| Q2 2021 | 2021-06-30 | $7.2M | $3.8M | +109.25% |
| Q1 2021 | 2021-03-31 | $6.0M | — | — |
| Q3 2020 | 2020-09-30 | $2.9M | — | — |
| Q2 2020 | 2020-06-30 | $3.5M | — | — |
Rani Therapeutics Holdings operating expenses trends
Over the last five fiscal years, Rani Therapeutics Holdings's operating expenses increased from $17.0M to $39.9M, a change of $22.9M. The latest reported quarter, Q2 2026, shows $10.5M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Rani Therapeutics Holdings source filings ↗